Skip to main content
About Us
Joining I-BFM
Members
History
Events
Articles
Structure
Associated Working Groups and Task Forces
Board of Directors, Advisory Group and Assembly of Delegates
Committees
Acute Lymphoblastic Leukaemia Committee (ALL)
Acute Myeloid Leukaemia Committee (AML)
Biology and Diagnosis Committee (B&D)
Chronic Myeloid Leukaemia Committee (CML)
Early and Late Toxicity Education Committee (ELTEC)
Early Clinical Trials Committee (ECT)
Genetic Variation (GV)
Information Management and Methodology Committee (IMM)
Non-Hodgkin Lymphoma Committee (NHL)
Resistant Disease Committee (ResD)
Stem Cell Transplantation Committee (SCT)
Annual Meeting
Clinical Trials
Contact
Legal establishment of I-BFM-SG as a registered organization
Home
Articles
Page 2
Overview
Legal establishment of I-BFM-SG as a registered organization
02. May 2024
We are pleased to announce the successful legal transformation of the I-BFM into a registered association under German law. This important change marks a significant milestone in our organization's development, providing a robust legal framework to support our mission and scientific activities.
More
EOI2 flow-MRD as an independent prognosticator
30. March 2023
New study showing the utility of EOI2 flow-MRD as an independent prognosticator for risk stratification in children
More
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia
20. March 2023
New study demonstrating that hypodiploidy has unfavorable impact on survival in children.
More
In Memoriam: Giuseppe Basso
01. April 2021
Our friend, Pediatric Cancer Specialist and professor of Pediatrics, Giuseppe Basso, “Beppe” for the friends, died Tuesday, February 16 from complications of Covid-19 infection.
More
Previous page
1
2
